PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
21-Apr-2026 Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products Businesswire
21-Apr-2026 World-leading NAD specialists join NADMED to advance redox metabolite diagnostics NADMED
21-Apr-2026 Trump Pushes Cannabis Rescheduling as Hemp CMS Issues Play Out in Federal Court ACCESS Newswire
21-Apr-2026 ImmunityBio Announces ANKTIVA® Is Now Available in Saudi Arabia for Bladder and Lung Cancer Patients; Market Entry Achieved Within Two Months of MENA Partnership Businesswire
21-Apr-2026 Biocon Receives Health Canada Approval of Bosaya™ (Denosumab) and Vevzuo™ (Denosumab), Biosimilars to Prolia® and Xgeva® Businesswire
21-Apr-2026 Zephyr AI Appoints Dr. Lisa Eli as Chief Scientific Officer Businesswire
21-Apr-2026 Versiti Clinical Trials Services Partners with 4D Path to Accelerate Personalized Cancer Treatment Development Businesswire
21-Apr-2026 StenTech Acquires Pentagon EMS to Further Enhance Tooling Capabilities Businesswire
21-Apr-2026 Dot Compliance Launches Dottie AI 5.0, Introduces Agentic AI Personas to Power the Future of Hybrid Workforces Dot Compliance
21-Apr-2026 Compass Pathways Collaborates with Osmind to Advance Independent Clinic Readiness for Psychedelic Treatments Businesswire
21-Apr-2026 Norton Leatherman Spine Surgeon Makes History With First in World Use of New Spine Surgery Robot ACCESS Newswire
21-Apr-2026 MedaSystems Introduces Next-Generation Enhancements to Transform User Experience Businesswire
21-Apr-2026 3Aware Launches Evidence Vault to Help Health Systems Turn Clinical Data into Scalable Research and Revenue ACCESS Newswire
21-Apr-2026 Justera Announces CFO Appointments ACCESS Newswire
21-Apr-2026 GEn1E and Rubicon Research Announce Strategic Partnership to Advance AI-Driven Precision Immunomodulators Businesswire
21-Apr-2026 Cosmos Health Introduces the "18 Series" in the United States - A Science-Driven Nutraceutical Platform Built on Patented Ingredients, Published Clinical Research, and Exact Clinical Dosing; Targeting a Portfolio of 18 Clinically Validated Products ACCESS Newswire
21-Apr-2026 d-wise Appoints 2x-CEO, ex-Labcorp Head of Software Solutions to Drive Next Phase of Strategy & Growth Businesswire
21-Apr-2026 Richmond Pharmacology Appoints John Hotti as Chief Technology Officer Richmond Pharmacology
21-Apr-2026 Glioblastoma Disrupts the Brain Far Beyond the Tumor PR&D
21-Apr-2026 BioInvent to Present Data of BI-1808 Plus KEYTRUDA(R) (Pembrolizumab) in Recurrent Ovarian Cancer at the 2026 ASCO Annual Meeting ACCESS Newswire